Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound... ( PRINCETON N.J. April 15 /- Pharma...)

HOME >> MEDICINE >> TECHNOLOGY

Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540

Date:4/15/2008

PRINCETON, N.J., April 15 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that results from the company's Phase 2a clinical trial evaluating PS433540, its first-in-class Dual Acting Receptor Antagonist (DARA), will be presented as a late-breaking clinical trial at the American Society of Hypertension (ASH) Twenty-Third Annual Scientific Meeting and Exposition in New Orleans, May 14-17, 2008.

PS433540 is being developed as a potential treatment for both hypertension and diabetic nephropathy and is the first and only blood pressure product candidate in development that possesses two validated mechanisms of action in a single compound.

Joel Neutel, MD, lead investigator and Director of Research, Orange County Research Center, Tustin, Calif., will present results of the Phase 2a clinical trial. In addition to the late-breaker, Pharmacopeia will also present data from its Phase 1 Multiple Ascending Dose (MAD) Study of PS433540.

Late-breaker presentation:

-- "A Double Blind, Placebo Controlled Study to Evaluate the Safety and

Efficacy of a Novel New Dual Acting Receptor Antagonist (DARA

Compound) in Human Subjects with Hypertension"

-- Friday, May 16, 2008, 5:38 - 5:55 p.m. CDT (6:38 - 6:55 p.m. EDT)

-- New Orleans Marriott, Acadia Ballroom, 3rd Floor

Poster presentation:

-- "PS433540 a Novel Dual Acting Receptor Antagonist Dose Dependently

Increases Plasma Renin Activity in Healthy Volunteers"

-- Abstract # P-14

-- Wednesday, May 14, 2008, Posters on Display: 3:00 - 7:00 p.m. CDT

(4:00 - 8:00 p.m. EDT), Poster Discuss
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)
2. Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)
3. Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development
4. Pharmacopeia to Present at BIO CEO & Investor Conference 2008
5. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
6. Pharmacopeia Announces Third Quarter 2007 Financial Results
7. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
8. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
9. Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
10. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
11. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria

Post Your Comments:

(Date:5/24/2013)... May 24, 2013 Solta Medical, Inc. (NASDAQ: ... market, today reported Dr. Edward W. Knowlton ... of Directors effective immediately. Dr. Knowlton is the founder of ... as a director since 1996. "On behalf of ... team, I would like to thank Ed for his tireless ...

(Date:5/24/2013)... 24, 2013 Auxilium Pharmaceuticals, Inc. (Nasdaq: ... in the Deutsche Bank Health Care Conference to be ... Mr. Adrian Adams , Chief Executive ... of the Company and its product pipeline at 12:00 ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation ...

(Date:5/24/2013)... GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, is ... Usui as a Consultant to augment the Company,s business ... territories. Mr Usui has more than 15 years of ... industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ( ...

Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2 Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2 Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3 Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4 Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2

[0] Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.[0] Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference [0] Heptares Augments Business Development Capabilities in Japan and Other Asian Territories

... (NASDAQ: CYBX ), a global leader in epilepsy ... year ended April 29, 2011. Annual ... the fifty-three week fiscal 2010, without adjustment for the extra ... $190.5 million, a 14% increase from $167.8 million; U.S. ...

... China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED ), ... financial results for the fourth fiscal quarter ("4Q FY2010") and the ... FY20 10 Highlight sFor ... EndedMarch 31, 2010March ...

Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results

(Date:5/25/2013)... (PRWEB) May 25, 2013 On May 20, ... people do not wish to discuss or plan for their ... FuneralFinancials.com released a Must-Do List to help ... Funeral Financials recommends, “Creating a personal fact sheet.” , While ... organize financial information and personal data. It may include ...

(Date:5/25/2013)... York,NY (PRWEB) May 25, 2013 By ... officially declared the integration of the 2012 Lamborghini ... Aventador is the latest entrant in the list of ... intelligently, the vehicle is all set to thrill automobile ... vicious acceleration power and spectacular looks, the 2012 Lamborghini ...

(Date:5/25/2013)... Many orthodontists have thought about moving their ... cloud is. Most people would naturally assume that ... their cloud service and support would own and maintain ... selling, they'd be wrong. Cloud providers lease space ... facility that houses servers and related equipment to run ...

(Date:5/25/2013)... NJ (PRWEB) May 25, 2013 Acuity ... The universal app version of Word Hunt is ... versions of Concentration, Edge Match, Flash 2, Sudoku and Matchematics ... The brain games’ gameplay and revolutionary lifetime brain fitness measurement ... inch displays. , “100 years of brain fitness measurement in ...

(Date:5/25/2013)... Bradley, Illinois (PRWEB) May 25, 2013 ... assisted living community, is hosting an American Red Cross ... May 30. , The community, which is located at ... of all incomes, including those on Medicaid, who need ... give the Gift of Life," says Andrea Arview Frey, ...

Breaking Medicine News(10 mins):Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2 Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2 Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2 Health News:Acuity Games Apps Come to the iPhone 2 Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2

[0] FuneralFinancials.com Releases Last Wishes Must-Do List [0] Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador [0] Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other [0] Acuity Games Apps Come to the iPhone [0] Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive

... The ... by more than 30% to meet the growing demand by medical practitioners to enhance and ... ... -- The Laser Warehouse has increased its inventory of used cosmetic lasers and other used ...

... ... the public to share their personal stories and utilizes social media to spread the word. ... Newcastle, ME (Vocus) July 8, 2010 ... resulted in a special video project and upcoming book. The Social Security Stories Project ...

... Gardner HealthDay Reporter , THURSDAY, July 8 (HealthDay ... throat cancers may also raise the risk of developing squamous ... a new study suggests. The risk from human papillomavirus ... people are taking drugs such as glucocorticoids to suppress the ...

... ... care staff offer new career opportunities for ambitious professionals. , ... (PRWeb UK) July 9, 2010 -- HCL International, the leading ... high turnout of GPs and social workers interested in working in ...

... ... work helping sea turtle conservation efforts in Magdalena Bay with 3 days sea kayaking ... experience necessary. , ... Loreto, Baja California (PRWEB) July 9, 2010 -- Idaho-based Sea Kayak Adventures, Inc. is ...

... ... multi-platinum group the Jonas Brothers, was announced today as the National Chair of Juvenile ... ... Grammy-nominated, multi-platinum group the Jonas Brothers, was announced today as the National Chair of ...

Cached Medicine News:Health News:The Laser Warehouse Increases its Inventory of Used Cosmetic Lasers to Meet Growing Demand 2 Health News:The Laser Warehouse Increases its Inventory of Used Cosmetic Lasers to Meet Growing Demand 3 Health News:Project captures Social Security "Stories," Seeks Additional Submissions from Public 2 Health News:Project captures Social Security "Stories," Seeks Additional Submissions from Public 3 Health News:Study Suggests Link Between HPV, Skin Cancer 2 Health News:Study Suggests Link Between HPV, Skin Cancer 3 Health News:HCL International: Australia a Favourite Destination for UK Social Workers and GPs 2 Health News:HCL International: Australia a Favourite Destination for UK Social Workers and GPs 3 Health News:Help Save Sea Turtles and Kayak Loreto Baja this October 2 Health News:Help Save Sea Turtles and Kayak Loreto Baja this October 3 Health News:Nick Jonas to be National Chair of JDRF's Walk to Cure Diabetes 2 Health News:Nick Jonas to be National Chair of JDRF's Walk to Cure Diabetes 3 Health News:Nick Jonas to be National Chair of JDRF's Walk to Cure Diabetes 4

The Laser Warehouse Increases its Inventory of Used Cosmetic Lasers to Meet Growing Demand Project captures Social Security "Stories," Seeks Additional Submissions from Public Study Suggests Link Between HPV, Skin Cancer HCL International: Australia a Favourite Destination for UK Social Workers and GPs Help Save Sea Turtles and Kayak Loreto Baja this October Nick Jonas to be National Chair of JDRF's Walk to Cure Diabetes

... an automated, turbidimetric, whole- blood assay designed ... ability of activated platelets to bind to ... the VerifyNow IIb/IIIa assay device contains all ... analysis. Within the well is an activator ...

... The ComboMap system provides both pressure ... either singly or in a combined ... performance SmartWire and Volcano's unique Doppler ... with valuable tools to assess ambiguous ...

... Introducing a surgical table that performs as ... 810! Designed for use in major surgical ... critical, the OPERON B 810 brings better ... table provides flexible articulation for maximum patient ...

... Clearview Strep A Exact ... direct detection of Group A ... , ,Clearview Strep A ... technology to provide highly sensitive ...

Medicine Products:

VerifyNow IIb/IIIa Assay ComboMap Pressure and Flow System The OPERON B 810 Clearview Strep A Exact